Barrett's esophagus: Clinical characteristics

Gastroenterology Clinics of North America

Volumn 31, Issue 2, 2002, Pages 441-460

  Reynolds, James C ^a   Rahimi, Poneh ^a   Hirschl, David ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIC; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; METAPLASIA; METASTASIS; MORBIDITY; MORTALITY; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; ESOPHAGUS TUMOR; INCIDENCE; PROGNOSIS; RISK ASSESSMENT; UNITED STATES;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; HUMAN; INCIDENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; HUMANS;

EID: 0035992185     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(02)00019-5     Document Type: Review

References (88)

1. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systemic review
2. Continuing climb in rates of esophageal adenocarcinoma: An update
3. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
4. Barrett's esophagus: Age, prevalence, and extent of columnar epithelium
5. Prevalence of columnar-lined (Barrett's) esophagus: Comparison of population based clinical and autopsy findings
6. Barrett's esophagus and adenocarcinoma. Prevalence and incidence in Olmsted County
7. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
8. Extent of Barrett's metaplasia: A prospective study of the serial change in area of Barrett's measured by quantitative endoscopic imaging, 1996
9. Adenocarcinoma of the esophagus and gastric cardia: Medical conditions, tobacco, alcohol, and socioeconomic factors
10. Time-tied and age-period-cohort effects on incidence of esophageal cancer in Connecticut 1935-1989
11. Management of adenocarcinoma in columnar-lined esophagus
12. Progress in treating esophageal adenocarcinoma
13. Micrometastases in esophagogastric cancer: High detection rate in resected rib segments
14. Superficial carcinoma of the esophagus
15. Gastrointestinal manifestations of scleroderma
16. A guide for surveillance of patients with Barrett's esophagus
17. Dysplasia in short-segment Barrett's esophagus: A prospective 3-year follow-up
18. Risk of extraesophageal malignancy in patients with adenocarcinoma arising in Barrett's esophagus
19. Barretts esopahagus: A new look at survaillance based on emerging estimates of cancer risk
20. Prognosis of adenocarcinoma arising in Barrett's esophagus
21. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
22. Adenocarcinoma arising in Barrett's esophagus: Evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence
23. Clinical implications of the p53 tumor-suppressor gene
24. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma
25. Barrett's esophagus, its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux
26. Effect of benzo (a)pyrene diol epoxide on expression of retinoic acid receptor-B in immortalized esophageal epithelial cells and esophageal cancer cells
27. Symptomatic gastroesophageal reflux as a risk factor for esophageal carcinoma
28. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort
29. Barrett's esophagus in childhood
30. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett's) esophagus
31. Barrett's esophagus: Current assessment and future perspectives
32. Barrett's esophagus: Comparison of benign and malignant cases
33. Barrett's esophagus: A surgical entity
34. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction
35. Adenocarcinoma of the esophagus: Role of obesity and diet
36. Adenocarcinoma of the esophagus and esophagogastric junction in White men in the United States: Alcohol, tobacco, and socioeconomic factors
37. Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in Barrett's esophagus
38. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
39. Etiology of Barrett's metaplasia and esophageal adenocarcinoma
40. Quantitative endoscopy: Precise computerized measurement of metaplastic epithelial surface area in Barrett's esophagus
41. Adenocarcinoma of the lwer eophagus: A disease primarily of white men with Barrett's eophagus
42. Does this patient have Barrett's esophagus? The utility of predicating Barrett's esophagus at the Index Endoscopy
43. The columnar-lined (Barrett's) oesophagus in black patients
44. Prevalence of Barrett's esophagus in Hispanics in similar to Caucasians
45. Tobacco, alcohol and socioeconomic status and adenocarcinoma of the esophagus and gastric cardia
46. Obesity, alcohol and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma
47. Risk factors for developing squamous cell cancer of the esophagus
48. Effect of smoking on lower esophageal sphincter
49. Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus
50. The consumption of tobacco, alcohol, and the risk of adenocarcinoma in Barrett's esophagus
51. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia
52. Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population
53. Extended and limited type of Barrett's esophagus in the adult
54. Prospective long-term endoscopic and histologic follow-up of short segment Barrett's esophagus: Comparison with traditional long segment Barrett's esophagus
55. Presence of a field defect in Barrett's esophagus leads to incremental expression of P53 adjacent to esophageal adenocarcinoma
56. Length of Barrett's oesophagus: An important factor in the development of dysplasia and adenocarcinoma
57. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data
58. Adenocarcinoma arising in tongues or short segment of Barrett's esophagus
59. Association between body mass and adenocarcinoma of the esophagus and gastric cardia
60. Risk factors in the development of Barrett's metaplasia
61. Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus
62. Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects
63. Difference in nutritional and environmental exposures in patients with Barrett's and GERD
64. Rising incidence rate of esophageal adenocarcinoma and use of pharmacologic agents that relax the lower esophageal sphincter (United States)
65. Barrett's esophagus: Continuing questions and controversy
66. Systemic sclerosis (sclerodermal) and esophageal adenocarcinoma: Is increased screening necessary?
67. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications
68. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia
69. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation
70. Observer variation in the diagnosis of dysplasia in Barrett's esophagus
71. Post-irradiation somatic mutation and clonal stabilization time in human colon
72. Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: Pathological and prognostic correlations
73. Potential application of p53 as an intermediate biomarker in Barrett's esophagus
74. Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma
75. Discordance between flow cytometry abnormalities and dysplasia in Barrett's esophagus
76. Barrett's esophagus: Electrocoagulation
77. Photodynamic therapy for Barrett's esophagus: Clinical update
78. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus
79. High levels of p53 protein in UV-irradiated normal human skin
80. Endoscopic treatment of esophagogastric tumors
81. Endoscopic therapy of Barrett's oesphagus
82. Progression of columnar esophageal (Barrett's) epithelium after anti-reflux therapy
83. Lack of effective therapy on extent of Barrett's esophagus - 67 Patients
84. Biomarker studies in reversed Barrett's esophagus
85. Suqamous islands in Barrett's esophagus: What lies underneath?
86. Barrett's espohagus
87. The role of tabacco, snuff and alcohol use in the etiology of cancer of the oesophagus and gastric cardia